acute coronary syndrome
AMP Working Group Recommends Alleles to Include in Warfarin Sensitivity Genotyping Assays
The group said the recommendations aim to standardize and improve warfarin response genotyping assays.
The Finnish diagnostics company is working to expand US and European sales of its ceramide lipid-based cardiovascular risk assessment assay, CERT.
Clinicians need to understand higher-sensitivity troponin assays will detect longer-term cardiac injury as well as acute conditions, experts say.
Alere Settles With DOJ for $33.2M
The company will pay the US $33.2 million to settle allegations that it caused hospitals to submit false claims to federal healthcare programs.
Backed by €19 million in EU funding, the initiative, called BigData@Heart, will create a research platform that could change the way cardiovascular diseases are diagnosed and treated.